Efficacy and safety of NOAC versus warfarin in AF patients with left atrial enlargement.
Victor Chien-Chia WuChun-Li WangShu-Ting GanMichael WuShao-Wei ChenChang-Fu KuoYu-Tung HuangMing-Shien WenShang-Hung ChangPublished in: PloS one (2020)
In elderly patients with AF and LAE, NOAC was associated with reduced IS/SE and death from any cause compared with warfarin, whereas no difference in major bleeding was observed between these treatments.